Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALCINA 5: Circulating Tumor Markers in NSCLC
NCT07060950Not yet recruiting
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Oct 2025
- Primary completion
- Jul 2030
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Study of the feasibility of detecting and/or analysing blood or tissue tumour biomarkers at 10 years. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07060950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07060950.